News

The ProFAST+ assay is a multiplex, real-time RT-PCR (polymerase chain reaction) test that detects influenza A from nasopharyngeal swabs. It uses the same internal control and format as

Alcon’s operating income rose 18.8% to $751m, or 39.8% of sales. Non-GAAP adjusted operating income would have increased 19.5% to $755m, or 40.0% of sales. Net earnings in

Ampio and DMI said that the acquisition is expected to provide Ampio access to all rights, royalties and patents associated with DMI’s assets, drugs for male sexual dysfunction

Tibotec Pharma said that, TMC278 will be the third anti-HIV compound to be introduced by the company, if approved by FDA. Tibotec Pharma has applied for the approval

With the completion of this acquisition, QPS further expands its linearly integrated resources and services which consists of drug discovery and development from preclinical to clinical studies for

Abviva said that the Mammastatin technology continues to increase its protection as evidenced by the grant of patents around its core technology. Reportedly, in recent months, the Japanese

Triaminic fever reducer pain reliever temporarily reduces fever and relieves minor aches and pains due to the common cold, flu, headache, minor sore throat, and toothache. The product

Teva Pharma has posted a net income of $800m for the second quarter 2010, or $ 0.88 per diluted share, compared to $523m or $0.58 per diluted share

Before being appointed in NexMed Dr Hachicha worked as a senior principal scientist in the pharmacology and drug discovery department at Forest Laboratories, from 2005 to 2010, where